These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3718541)

  • 1. New heterocyclic modifiers of oxidative drug metabolism--I. 6-Substituted-2-aminobenzothiazoles.
    Murray M; Lacey E; Farrell GC
    Biochem Pharmacol; 1986 Jun; 35(12):1971-9. PubMed ID: 3718541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic aspects of the inhibition of microsomal drug oxidation by primaquine.
    Murray M; Farrell GC
    Biochem Pharmacol; 1986 Jul; 35(13):2149-55. PubMed ID: 3729971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro effects of quinoline derivatives on cytochrome P-450 and aminopyrine N-demethylase activity in rat hepatic microsomes.
    Murray M
    Biochem Pharmacol; 1984 Oct; 33(20):3277-81. PubMed ID: 6487376
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of rat hepatic microsomal aminopyrine N-demethylase activity by benzimidazole derivatives. Quantitative structure-activity relationships.
    Murray M; Ryan AJ; Little PJ
    J Med Chem; 1982 Aug; 25(8):887-92. PubMed ID: 7120277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The binding to oxidised cytochromes P-450 and inhibition of mixed-function oxidases by aryl-substituted benzimidazoles and related compounds.
    Murray M; Ryan AJ
    Chem Biol Interact; 1983 Mar; 43(3):341-51. PubMed ID: 6825202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatic microsomal monooxygenase activity by cinchocaine: mechanistic studies and effects of ionization.
    Murray M
    J Pharm Pharmacol; 1986 Jun; 38(6):472-5. PubMed ID: 2873227
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selective inhibitory interactions of alkoxymethylenedioxybenzenes towards mono-oxygenase activity in rat-hepatic microsomes.
    Murray M; Hetnarski K; Wilkinson CF
    Xenobiotica; 1985 May; 15(5):369-79. PubMed ID: 4036165
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of arylalkybenzimidazoles and related compounds with microsomal oxidation.
    Murray M; Ryan AJ
    Xenobiotica; 1983 Dec; 13(12):707-14. PubMed ID: 6675324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New heterocyclic modifiers of oxidative drug metabolism--II. Steric factors in the interaction of isomeric 2-(naphthyl)methylbenzimidazoles with rat hepatic microsomal cytochrome P-450 and monooxygenase activities.
    Murray M
    Biochem Pharmacol; 1987 Feb; 36(4):463-8. PubMed ID: 3493778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro metabolism of azasqualene derivatives and their effects on aminopyrine N-demethylase activity in rat liver microsomes.
    Viola F; Grosa G; Ceruti M; Caputo O; Cattel L
    Biochem Pharmacol; 1989 Aug; 38(15):2497-503. PubMed ID: 2757649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of rat liver monooxygenase activities by 2-methyl-1,4-naphthoquinone (menadione).
    Floreani M; Carpenedo F
    Toxicol Appl Pharmacol; 1990 Sep; 105(2):333-9. PubMed ID: 2219123
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The relationship between the binding of 2-n-alkylbenzimidazoles to rat hepatic microsomal cytochrome P-450 and the inhibition of monooxygenation.
    Dickins M; Bridges JW
    Biochem Pharmacol; 1982 Apr; 31(7):1315-20. PubMed ID: 7092924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of antithrombitic and antimycotic N-substituted imidazoles on rat hepatic microsomal steroid and xenobiotic hydroxylases in vitro.
    Murray M; Zaluzny L
    Biochem Pharmacol; 1988 Feb; 37(3):415-20. PubMed ID: 3337742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of pyridine and some pyridine derivatives on spectral properties of reduced microsomes and on microsomal drug metabolizing activity.
    Jonen HG; Hüthwohl B; Kahl R; Kahl GF
    Biochem Pharmacol; 1974 Apr; 23(8):1319-29. PubMed ID: 4824776
    [No Abstract]   [Full Text] [Related]  

  • 15. A class of strong inhibitors of microsomal monooxygenases: the ellipticines.
    Lesca P; Rafidinarivo E; Lecointe P; Mansuy D
    Chem Biol Interact; 1979 Feb; 24(2):189-97. PubMed ID: 428009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Changes in rat hepatic microsomal mixed function oxidase activity following exposure to halothane under various oxygen concentrations.
    Knights KM; Gourlay GK; Cousins MJ
    Biochem Pharmacol; 1987 Mar; 36(6):897-906. PubMed ID: 3105540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-competitive and competitive inhibition of mixed function oxidase in rat liver microsomes by metyrapone.
    Roots I; Hildebrandt AG
    Naunyn Schmiedebergs Arch Pharmacol; 1973; 277(1):27-38. PubMed ID: 4350469
    [No Abstract]   [Full Text] [Related]  

  • 18. Nitrite binding to rabbit liver microsomes and effects on aminopyrine demethylation.
    Shertzer HG; Duthu GS
    Biochem Pharmacol; 1979 Mar; 28(6):873-9. PubMed ID: 36902
    [No Abstract]   [Full Text] [Related]  

  • 19. Structure-activity relationships in the interactions of alkoxymethylenedioxybenzene derivatives with rat hepatic microsomal mixed-function oxidases in vivo.
    Murray M; Wilkinson CF; Marcus C; Dubé CE
    Mol Pharmacol; 1983 Jul; 24(1):129-36. PubMed ID: 6865922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of 2-mercaptopropionylglycine on lipid peroxidation and drug oxidation in rat liver microsomes.
    Harata J; Nagata M; Ishiguro I; Ohta Y
    Biochem Int; 1984 Jan; 8(1):49-59. PubMed ID: 6477598
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.